Amanote Research
Register
Sign In
Efavirenz Directly Modulates the Oestrogen Receptor and Induces Breast Cancer Cell Growth
HIV Medicine
- United Kingdom
doi 10.1111/j.1468-1293.2010.00831.x
Full Text
Open PDF
Abstract
Available in
full text
Categories
Health Policy
Infectious Diseases
Pharmacology
Date
September 3, 2010
Authors
MJ Sikora
JM Rae
MD Johnson
Z Desta
Publisher
Wiley
Related search
Coadministration of Nanosystems of Short Silencing RNAs Targeting Oestrogen Receptor Α and Anti-Oestrogen Synergistically Induces Tumour Growth Inhibition in Human Breast Cancer Xenografts
Breast Cancer Research and Treatment
Cancer Research
Oncology
Role of the Hsp90 Cochaperone, FKBPL, in Oestrogen Receptor Signalling and Breast Cancer Growth and Survival
Breast Cancer Research
Cancer Research
Oncology
Reproductive Risk Factors and Oestrogen/Progesterone Receptor-Negative Breast Cancer in the Breast Cancer Family Registry
British Journal of Cancer
Cancer Research
Oncology
The Role of Oestrogen and Progesterone Receptors in Breast Cancer – Immunohistochemical Evaluation of Oestrogen and Progesterone Receptor Expression in Invasive Breast Cancer in Women
Wspolczesna Onkologia
Oncology
Radiology
Nuclear Medicine
Imaging
The Evolving Role of Oestrogen Receptor Β in Clinical Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Extreme Growth Factor Signalling Can Promote Oestrogen Receptor-Α Loss: Therapeutic Implications in Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
A Meta-Analysis of Oestrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Discordance Between Primary Breast Cancer and Metastases
European Journal of Cancer
Cancer Research
Oncology
Oestrogen Receptor Status and Survival in Women With BRCA2-associated Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Menopausal Oestrogen Use and Breast Cancer.
BMJ
